Systematic review / meta-analysis / 2014
Oral melatonin significantly elevates post-intervention melatonin levels in older adults in a dose-dependent manner.
A systematic review of 16 articles evaluated the dose-response effect of oral exogenous melatonin (0.1 mg to 50 mg/kg) on melatonin levels in adults aged 55 years and older. Pre- and post-intervention measurements showed a significant, dose-dependent elevation of post-intervention melatonin levels. Maximum concentrations in serum and urine were elevated compared with placebo, showing higher elevations in older than in younger adults. While time to maximum concentration did not differ, higher doses maintained levels longer above a threshold than lower doses.
- Study type
- Systematic review of 16 studies (9 RCTs)
- Who was studied
- Older adults aged 55 years and above (mean age 55.3 to 77.6 years across studies)
- What was measured
- Endogenous melatonin levels in serum, urine, or saliva (including maximum concentrations and time to maximum concentration)
THE PAPER
Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature.
Vural EM, van Munster BC, de Rooij SE. Drugs Aging, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.